News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Anavex Life Sciences Corp. (AVXL.OB) Provides Business Update Including Clinical Trial Plans For ANAVEX PLUS In Alzheimer's Disease


5/15/2014 11:52:06 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK, May 15, 2014 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (OTCQB:AVXL), a clinical-stage biopharmaceutical company developing novel drug candidates to treat Alzheimer's disease, other diseases of the central nervous system (CNS) and various types of cancer, today provided a business update including clinical trial plans for its lead drug candidates in Alzheimer's disease (AD). - See more at: http://www.globenewswire.com/news-release/2014/05/15/636743/10081859/en/Anavex-Provides-Business-Update-Including-Clinical-Trial-Plans-for-ANAVEX-PLUS-in-Alzheimer-s-Disease.html#sthash.768i4KeB.dpuf

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES